Luminai Secures $38 Million in Series B Funding to Enhance Healthcare Operations with AI

Luminai Raises $38 million Series B to Enhance Healthcare Operations

On April 9, 2026, Luminai, a platform dedicated to enterprise automation specifically crafted for the healthcare industry, announced that it has successfully concluded a Series B funding round amounting to $38 million. This recent investment raises the company’s total capital to an impressive $60 million. The funding was spearheaded by Peak XV Partners (formerly known as Sequoia India and Southeast Asia), with new stakeholders such as Define Ventures joining existing investors including General Catalyst and Y Combinator.

This financial boost comes at a pivotal moment for large healthcare providers, who are under increasing pressure to modernize their administrative operations amid rising costs, staffing shortages, and complicated operational frameworks. Shailendra Singh, the Managing Partner at Peak XV Partners, emphasized the unique position of Luminai by stating, “Their platform approach addresses a historically fragmented problem in healthcare operations. Unlike typical vendors who optimize single tasks, Luminai constructs an intelligent layer meant to redefine operational workflows in the healthcare sector.”

The healthcare industry faces numerous challenges such as fragmented information, outdated technology, and processes reliant on manual input, which leads to high operational costs. Research estimates that administrative tasks may account for up to 25% of total healthcare expenditures. Much of this expense arises from the coordination of disconnected systems, resulting in cumbersome and inefficient operations. In response to these challenges, healthcare organizations are increasingly moving towards integrated platforms that offer adaptive solutions for a wide array of use cases over time.

Kesava Kirupa Dinakaran, the Founder and CEO of Luminai, pointed out the tremendous complexities inherent in automating healthcare administrative functions. He noted that traditional methods of translating manual workflows into effective software systems have been cumbersome due to disjointed systems and the necessity for nuanced understanding of both business operations and clinical contexts. However, advancements in artificial intelligence have made it feasible to manage this complexity directly, allowing for the reliable execution of intricate workflows rather than just automating isolated tasks.

Luminai is committed to establishing an AI-native infrastructure that can adapt as healthcare environments evolve. This funding round equips them to expand their platform further and better meet the increasing demands of health systems. Combing expertise from AI specialists with a background from notable organizations such as Palantir, Cruise, Google, and many others in the healthcare domain, Luminai’s team is well-prepared to navigate and improve the high-stakes landscape of healthcare operations.

The platform Luminai has developed is specifically designed to address the operational complexities synonymous with healthcare systems. It leverages healthcare-trained artificial intelligence to process unstructured data, ensuring reliable results while coordinating tasks across various domains such as patient access, revenue cycle management, compliance, and other administrative duties.

With the proceeds from the Series B funding, Luminai plans to enhance its product offerings, expand its engineering team, and support an increasing number of enterprise customers as the appetite for scalable, reliable AI automation grows in the healthcare sector. Luminai’s unique approach is paving the way for a transformative change in how health organizations manage their operations, ultimately seeking to create a more efficient healthcare landscape for providers and patients alike.

For more information on Luminai, visit luminai.com where you can learn about their innovative solutions designed to refine healthcare operations through intelligent automation.